MedicaidCoverageMedium impact
BT202512: Pharmacy update approved by Drug Utilization Review Board January 2025
Indiana Medicaid (IHCP)·IN · Family Medicine, Internal Medicine, General Practice +3 more·Prior Authorization
Effective date
Mar 1, 2025
We identified it
Jun 19, 2026
Summary
Indiana Medicaid has updated its Statewide Uniform Preferred Drug List (SUPDL), Preferred Brand Drug List, and OTC Drug Formulary effective March 1, 2025 for fee-for-service and March 15, 2025 for managed care. Key changes include adding generic prucalopride and liraglutide as nonpreferred drugs, adding three brand medications to the preferred list, and covering diclofenac 1% gel as an OTC product.
Action Required
By March 1, 2025: Billing team must update prior authorization processes for Indiana Medicaid patients receiving prucalopride (generic Motegrity) and liraglutide (generic Victoza) injections as these are now nonpreferred and may require additional authorization steps. Update pharmacy benefit verification procedures to reflect new preferred status for brand Motegrity, Prostin VR, and Victoza. Verify coverage for diclofenac 1% gel as it is now a covered OTC product.